Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS DISHMAN PHARMA NEULAND LABS/
DISHMAN PHARMA
 
P/E (TTM) x 24.9 30.0 83.0% View Chart
P/BV x 7.9 3.3 237.2% View Chart
Dividend Yield % 0.2 0.7 24.5%  

Financials

 NEULAND LABS   DISHMAN PHARMA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
DISHMAN PHARMA
Mar-16
NEULAND LABS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,004374 535.3%   
Low Rs966129 749.3%   
Sales per share (Unadj.) Rs928.4197.0 471.3%  
Earnings per share (Unadj.) Rs127.421.2 601.5%  
Cash flow per share (Unadj.) Rs168.634.7 485.8%  
Dividends per share (Unadj.) Rs10.002.00 500.0%  
Avg Dividend yield %0.70.8 84.7%  
Book value per share (Unadj.) Rs774.8179.9 430.8%  
Shares outstanding (eoy) m12.8380.70 15.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.61.3 125.2%   
Avg P/E ratio x11.711.9 98.1%  
P/CF ratio (eoy) x8.87.3 121.5%  
Price / Book Value ratio x1.91.4 137.0%  
Dividend payout %7.89.4 83.1%   
Avg Mkt Cap Rs m19,05220,307 93.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0185,355 37.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,91215,898 74.9%  
Other income Rs m97265 36.7%   
Total revenues Rs m12,00916,163 74.3%   
Gross profit Rs m2,7184,103 66.3%  
Depreciation Rs m5281,091 48.4%   
Interest Rs m131944 13.8%   
Profit before tax Rs m2,1572,334 92.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m522624 83.8%   
Profit after tax Rs m1,6351,710 95.6%  
Gross profit margin %22.825.8 88.4%  
Effective tax rate %24.226.7 90.6%   
Net profit margin %13.710.8 127.6%  
BALANCE SHEET DATA
Current assets Rs m7,60911,018 69.1%   
Current liabilities Rs m4,3909,517 46.1%   
Net working cap to sales %27.09.4 286.3%  
Current ratio x1.71.2 149.7%  
Inventory Days Days657 11.2%  
Debtors Days Days1,1093 31,695.3%  
Net fixed assets Rs m8,18918,787 43.6%   
Share capital Rs m129161 79.9%   
"Free" reserves Rs m9,81214,354 68.4%   
Net worth Rs m9,94114,516 68.5%   
Long term debt Rs m7424,189 17.7%   
Total assets Rs m15,79829,805 53.0%  
Interest coverage x17.53.5 504.5%   
Debt to equity ratio x0.10.3 25.9%  
Sales to assets ratio x0.80.5 141.4%   
Return on assets %11.28.9 125.5%  
Return on equity %16.411.8 139.6%  
Return on capital %21.417.5 122.2%  
Exports to sales %73.524.9 295.2%   
Imports to sales %15.13.7 405.1%   
Exports (fob) Rs m8,7503,956 221.2%   
Imports (cif) Rs m1,804594 303.6%   
Fx inflow Rs m8,7504,952 176.7%   
Fx outflow Rs m1,804697 258.9%   
Net fx Rs m6,9464,255 163.2%   
CASH FLOW
From Operations Rs m2,3722,786 85.1%  
From Investments Rs m-615-1,529 40.2%  
From Financial Activity Rs m-1,358-941 144.3%  
Net Cashflow Rs m403317 127.4%  

Share Holding

Indian Promoters % 32.8 61.4 53.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 29.1 23.0 126.9%  
FIIs % 22.7 12.0 189.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 38.6 174.1%  
Shareholders   27,723 52,291 53.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NEULAND LABS vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs Dishman Pharma Share Price Performance

Period NEULAND LABS Dishman Pharma S&P BSE HEALTHCARE
1-Day -3.14% 2.87% 1.18%
1-Month -13.36% -2.45% -0.75%
1-Year 262.37% 96.38% 61.82%
3-Year CAGR 42.83% 89.34% 18.16%
5-Year CAGR 58.61% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.